Study Explores Drug Treatments for Early-onset Alzheimer’s disease

A recent clinical trial, funded in part by NIA, explored the impact of two drugs, gantenerumab or solanezumab, on symptoms and Alzheimer’s disease biomarkers among people with a rare type of early-onset dementia caused by genetic mutations. Researchers conducting the study…

Caring for a person with late-stage Alzheimer’s: Help with eating and swallowing

Many people in the later stages of Alzheimer’s disease lose interest in eating and may experience trouble with their chewing and swallowing. If a person with Alzheimer’s is not eating enough, he or she may not be getting the nutrients…